AP NEWS

Global Hemoglobin Testing Market 2018-2022 - Key Vendors are Abbott, Bio-Rad Laboratories, Danahar, EKF Diagnostics, F. Hoffmann-La Roche, Siemens Healthineers & Thermo Fisher Scientific - ResearchAndMarkets.com

August 29, 2018

DUBLIN--(BUSINESS WIRE)--Aug 29, 2018--The “Global Hemoglobin Testing Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.

The Global Hemoglobin Testing Market to grow at a CAGR of 8.14% during the period 2018-2022.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the retail sales of hemoglobin testing products, including instruments and consumables, and services across the globe.

One trend affecting this market is the growing preference for home care settings. Blood hemoglobin is a common method of detecting blood glucose levels and anemia in both acute care and outpatient settings.

According to the report, one driver influencing this market is the growing incidence of diabetes worldwide. The diabetes epidemic is spreading worldwide which is creating huge demand for effective and advanced hemoglobin testing devices to monitor blood glucose levels.

Further, the report states that one challenge affecting this market is the limitations of hemoglobin testing. Blood hemoglobin is the common indicator for diagnosing conditions like anemia, and diabetes, which is often determined by analyzing the blood sample of patients.

Key vendors

Abbott, Bio-Rad Laboratories Danahar EKF Diagnostics F. Hoffmann-La Roche Siemens Healthineers Thermo Fisher Scientific

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 05: MARKET SIZING 2017-2022

PART 06: FIVE FORCES ANALYSIS

Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

Comparison by end-user Healthcare centers Diagnostic laboratories Others Market opportunity by end-user

PART 09: REGIONAL LANDSCAPE

Geographical segmentation Regional comparison Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

Growing preference for home care settings Increasing use of POCT Availability of advanced testing devices Rise in elderly population

PART 13: VENDOR LANDSCAPE

PART 14: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/research/gwf7b8/global_hemoglobin?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180829005309/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Coagulation and Hemostasis Testing

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/29/2018 06:58 AM/DISC: 08/29/2018 06:58 AM

http://www.businesswire.com/news/home/20180829005309/en

AP RADIO
Update hourly